[go: up one dir, main page]

MD4231B1 - Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis - Google Patents

Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis Download PDF

Info

Publication number
MD4231B1
MD4231B1 MDA20120102A MD20120102A MD4231B1 MD 4231 B1 MD4231 B1 MD 4231B1 MD A20120102 A MDA20120102 A MD A20120102A MD 20120102 A MD20120102 A MD 20120102A MD 4231 B1 MD4231 B1 MD 4231B1
Authority
MD
Moldova
Prior art keywords
gastropathies
portal
treatment
carbazochrome
troxerutin
Prior art date
Application number
MDA20120102A
Other languages
Moldavian (mo)
Romanian (ro)
Other versions
MD4231C1 (en
Inventor
Gheorghe Anghelici
Ulviyya Mammadova
Oleg Crudu
Viorel Moraru
Original Assignee
Gheorghe Anghelici
Ulviyya Mammadova
Oleg Crudu
Viorel Moraru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gheorghe Anghelici, Ulviyya Mammadova, Oleg Crudu, Viorel Moraru filed Critical Gheorghe Anghelici
Priority to MDA20120102A priority Critical patent/MD4231C1/en
Publication of MD4231B1 publication Critical patent/MD4231B1/en
Publication of MD4231C1 publication Critical patent/MD4231C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, particularly to hepatology and can be used for the treatment of portal gastropathies in hepatic cirrhosis.Summary of the invention consists in that a medicament is used on the basis of troxerutin and carbazochrome, in a dose of 150 mg and, respectively, 1.5 mg, for the treatment of portal gastropathies in hepatic cirrhosis. At the same time, the medicament is administered 1 tablet, 2…3 times daily, per os, during 14…30 days.
MDA20120102A 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis MD4231C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Publications (2)

Publication Number Publication Date
MD4231B1 true MD4231B1 (en) 2013-06-30
MD4231C1 MD4231C1 (en) 2014-01-31

Family

ID=48749682

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20120102A MD4231C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis

Country Status (1)

Country Link
MD (1) MD4231C1 (en)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584926D1 (en) * 1984-03-01 1992-01-30 Lamorna Investments TREATMENT OF OEDEMS WITH HIGH PROTEIN CONTENT BY DIRECT APPLICATION OF BENZOPYRON.
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610B1 (en) * 1990-05-02 1994-09-30 Rhone Poulenc Sante NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
FR2661830B1 (en) * 1990-05-11 1992-09-04 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE.
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
FR2692145B1 (en) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger New composition for topical use containing diosmin.
FR2726469B1 (en) * 1994-11-08 1996-12-13 Adir PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
FR2778663B1 (en) * 1998-05-15 2001-05-18 Coletica NOVEL ESTERS OF FLAVONOIDS, THEIR USE IN COSMETICS, DERMOPHARMACY, PHARMACY AND AGRI-FOOD
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
KR20000019717A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease
KR100291141B1 (en) * 1998-09-15 2001-07-12 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
KR100291144B1 (en) * 2000-10-06 2001-05-15 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
KR100291145B1 (en) * 2000-10-06 2001-05-15 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
FR2845597B1 (en) * 2002-10-11 2005-03-11 Innothera Lab Sa DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED
US20040132816A1 (en) * 2003-01-06 2004-07-08 Liao Medical Corporation Lipid metabolism and fructus crataegus
FR2857665B1 (en) * 2003-07-16 2006-02-10 Centre Nat Rech Scient NOVEL FLAVON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
ITMI20050517A1 (en) * 2005-03-30 2006-09-30 Therapicon Srl PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
CN100444847C (en) * 2006-01-11 2008-12-24 刘展欣 Micronize diosmin and hesperidine composition suppository
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.

Also Published As

Publication number Publication date
MD4231C1 (en) 2014-01-31

Similar Documents

Publication Publication Date Title
MY159353A (en) Pirfenidone treatment for patients with atypical liver function
EA201591679A1 (en) METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE
MX2019007956A (en) SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT.
NZ732507A (en) Improved compositions for treating muscular dystrophy
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2011007589A (en) Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody.
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
JP2013155188A5 (en)
CL2014002935A1 (en) Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
PH12016502352A1 (en) Pharmaceutical composition
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
IN2015DN02999A (en)
MD4231B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD4458B1 (en) Use of Polybiolin drug in patients with liver cirrhosis
MX2015016678A (en) Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid.
MD3986C2 (en) Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
UA95834U (en) Method for treating acute ischemic stroke
UA82250U (en) Method for treating patients with non-alcoholic fatty liver disease
NZ600486A (en) Pirfenidone treatment for patients with atypical liver function
UA82641U (en) Method for treating neurosyphilis with parenchymatous alterations
UA93070U (en) Method of treatment of mucocutaneous candidiasis treatment with the patients having chronic pancreatitis

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)